This guide explains what underwriters evaluate when considering an applicant who has received a stint, realistic rate expectations, and how to improve your approval chances through optimal cardiac management.
Approval Likelihood
Rate Impact
Underwriting Timeline
Medical Testing
Understanding Heart Stents and Life Insurance
“Cardiac stent placement represents a significant underwriting event because it confirms substantial coronary artery disease. This is not a minor health event—it’s evidence of cardiovascular disease with ongoing risk. The key factors are time since stent placement, current cardiac function, symptom control, and disease progression. Best-case scenarios result in Table D ratings (175% of standard). More typical outcomes range from Table E to H (200-300% of standard) depending on individual circumstances.”
InsuranceBrokers USA – Management Team
Stents are placed in two primary scenarios: elective procedures for stable angina or chronic coronary disease, and emergency procedures during acute myocardial infarction (heart attack). The circumstances of your stent placement significantly affect underwriting outcomes. Emergency stenting during a heart attack indicates acute coronary syndrome with myocardial damage—a more serious event than elective stenting for stable disease.
Typically, underwriters will view stent recipients as individuals with confirmed, significant coronary artery disease requiring ongoing medical management and carrying substantial cardiovascular risk. As a result, standard rates become difficult to qualify for after stent placement. However, it may still be possible in some situations.
Critical Understanding: Receiving a stent is not like taking medication for high blood pressure. A stent represents documented coronary artery disease—a permanent change in your health status and insurability. You will face rate increases and coverage limitations for life. This isn’t unfair—it reflects the actuarial reality of coronary disease mortality risk. However, coverage is achievable with realistic expectations.
The Required Waiting Period After Stent Placement
Most life insurance carriers require a waiting period after stent placement before they’ll consider your application. This waiting period isn’t arbitrary—underwriters need time to assess whether your cardiac event was isolated, whether additional cardiac problems emerge, and whether you maintain stability on medical therapy.
Standard Waiting Periods
Typical waiting periods are 6-12 months after stent placement. Some carriers require only 6 months if the stenting was elective for stable disease with excellent results. Most carriers prefer 12 months, especially if the stent was placed during an acute myocardial infarction.
Applying before the waiting period expires results in automatic postponement. The carrier won’t decline your application—they’ll ask you to reapply after sufficient time has passed. This postponement protects both you and the carrier by ensuring adequate stability assessment.
What Happens During the Waiting Period
During this waiting period, your cardiologist will monitor your cardiac function, symptoms, and the effectiveness of your medication. You’ll typically have follow-up appointments, stress tests, and possibly repeat catheterization to assess stent patency and disease progression. Underwriters require follow-up documentation to demonstrate stability, absence of new cardiac events, preserved cardiac function, and adequate symptom control.
If you experience additional cardiac events during the waiting period—new chest pain, repeat catheterization, additional stents, heart failure symptoms—the waiting period resets. Each new cardiac intervention or complication restarts the clock. Underwriters need a clean period of stability before approval.
Important Timing: Don’t try to circumvent waiting periods by applying to multiple carriers immediately after stent placement. All carriers share underwriting information through the Medical Information Bureau (MIB). Multiple recent applications suggest you’re shopping for a carrier willing to ignore recent cardiac events, which creates red flags. Wait for the appropriate time, then apply when you can present a stable post-stent course.
What Underwriters Evaluate
After the waiting period, underwriters conduct a comprehensive evaluation of your cardiac status. They’re assessing not just that you survived stent placement, but your current cardiac function, disease extent, symptom control, and future risk. Multiple factors determine your rate class.
Reason for Stent Placement
Whether your stent was placed during an acute myocardial infarction or electively for stable angina significantly affects underwriting. Acute MI indicates you’ve had myocardial damage with potential for reduced cardiac function and increased future risk. Elective stenting for stable angina without MI suggests less severe disease with better prognosis. Your catheterization report will clearly document which scenario applies to you.
Number and Location of Stents
Single-vessel disease, requiring one stent, is underwritten more favorably than multi-vessel disease, which requires multiple stents. If you have one stent in the right coronary artery with no other coronary disease, you represent a lower risk than someone with three stents across all major coronary arteries. Underwriters carefully review your catheterization report to assess the extent of the disease.
Left main coronary artery disease is particularly concerning. The left main supplies large portions of the heart muscle. Stenting of the left main or complex multi-vessel disease results in a higher rate of increase than isolated single-vessel disease in smaller coronary branches.
Ejection Fraction and Cardiac Function
Your ejection fraction—the percentage of blood your heart pumps with each contraction—is one of the most critical underwriting factors. Normal ejection fraction (above 50-55%) indicates preserved cardiac function despite coronary disease. Reduced ejection fraction (below 40%) indicates significant myocardial damage with heart failure risk.
Underwriters require recent echocardiogram results documenting your current ejection fraction. If your ejection fraction is normal or only mildly reduced (45-50%), you’ll receive more favorable rates than someone with severely reduced function (below 35%). Heart failure symptoms or diagnosis substantially worsen underwriting outcomes.
Current Symptoms and Functional Capacity
Are you symptom-free since stent placement? Can you perform normal daily activities without chest pain or shortness of breath? Underwriters assess your functional capacity through stress test results, physician notes, and your symptom reports. Complete symptom resolution with good exercise capacity supports better rate outcomes.
Persistent angina despite stenting indicates inadequate revascularization or disease progression. This results in higher rates or possible postponement. Similarly, new-onset heart failure symptoms, shortness of breath, or reduced exercise tolerance signal complications requiring more conservative underwriting.
Disease Progression
Has your coronary disease progressed since stent placement? Have you required additional procedures, additional stents, or bypass surgery? Disease stability is crucial. One stent with no progression for 12+ months is underwritten favorably. Multiple procedures over time or progressive disease requiring escalating interventions result in significantly higher rates or possible decline.
Cardiovascular Risk Factors
Underwriters evaluate your other cardiovascular risk factors. Diabetes significantly worsens outcomes—diabetic patients with stents face higher rates than non-diabetic patients with similar coronary disease. Current smoking is particularly problematic and may result in decline or very high rates. Hypertension, high cholesterol, obesity, and family history of premature coronary disease all factor into rate assignments.
Underwriting Reality: These factors combine to create your overall risk profile. Best-case scenario: single stent for stable angina without MI, normal ejection fraction, no symptoms, no progression, and well-controlled risk factors. This might qualify for Table D (175% of standard). Worst-case scenario: multiple stents after acute MI, reduced ejection fraction, persistent symptoms, progressive disease, and uncontrolled diabetes. This results in Table H+ ratings (300%+ of standard) or possible decline.
Realistic Rate Expectations
Understanding realistic rate expectations prevents disappointment and helps you budget appropriately. Cardiac stent recipients face significant rate increases—there’s no way to sugarcoat this reality. However, coverage is accessible if you’re willing to pay the actuarially appropriate premiums.
Best-Case Scenario
Best-case outcomes—single stent, elective placement for stable angina without myocardial infarction, normal ejection fraction, complete symptom resolution, no progression for 12+ months— may qualify for a standard rate but will usually receive Table D ratings at best.
Typical Scenario
More typical outcomes—single or double stents, stable disease, normal or mildly reduced ejection fraction, minimal symptoms—receive Table E to F ratings. This is 200-225% of standard rates. The same $100 per month policy costs $200-$ 225 per month at these tables. Significantly more expense for sure, but at the same time, you are still able to qualify for coverage.
Complex Scenario
Complex presentations—multiple stents, acute MI, moderately reduced ejection fraction (35-45%), some persistent symptoms, or additional risk factors—receive Table G to H ratings. This is 250-300% of standard rates. That $100 per month policy costs $250-300 per month at these tables.
High-Risk Scenario
High-risk presentations—extensive multi-vessel disease, severely reduced ejection fraction (below 35%), heart failure, progressive disease, or poorly controlled risk factors—may receive Table H+ ratings (above 300% of standard) or face decline. Some carriers cap their maximum table ratings and decline applicants who exceed those limits.
Budget Reality: If you received a cardiac stent, you should budget for premiums at least double standard rates. This is a realistic baseline expectation. Yes, better outcomes are possible, but planning for 200%+ of standard prevents sticker shock. These rates reflect genuine mortality risk—they’re not arbitrary or negotiable.
Improving Your Approval Chances
While you can’t change the fact that you’ve had a stent placed, you can optimize your current cardiac management to achieve the best possible underwriting outcome. These actions may improve your rate class by one or two table ratings, potentially saving thousands of dollars over your policy lifetime.
Maintain Excellent Risk Factor Control
Control all modifiable cardiovascular risk factors aggressively. Keep blood pressure well-controlled—ideally below 130/80. Maintain excellent cholesterol control with LDL ideally below 70 mg/dL for secondary prevention. If you have diabetes, maintain HbA1c below 7%. Weight management, regular exercise within your cardiologist’s recommendations, and a heart-healthy diet all demonstrate commitment to cardiac health.
Medication Compliance
Take all prescribed cardiac medications exactly as directed. Most stent recipients take dual antiplatelet therapy (aspirin plus Plavix or similar), statins, beta blockers, and often ACE inhibitors or ARBs. Perfect medication compliance demonstrates you’re taking your cardiac disease seriously and reducing future risk. Medication gaps or non-compliance raise red flags.
Stop Smoking Completely
If you smoke, stopping is absolutely critical. Continued smoking after stent placement dramatically increases your risk of stent thrombosis, disease progression, and future cardiac events. Underwriters view continued smoking as a high-risk behavior that may result in decline or maximum table ratings. Some carriers won’t insure smoking stent recipients at any price. Stop completely—not just reducing, but complete cessation—and maintain at least 12 months of smoking-free status before applying.
Regular Cardiology Follow-Up
Maintain regular follow-up with your cardiologist and complete all recommended testing. Stress tests showing good functional capacity, echocardiograms showing preserved function, and catheterization reports (if repeated) showing stable disease all support better underwriting outcomes. Gaps in cardiology care or skipped follow-up appointments suggest poor disease management.
Wait for Optimal Timing
Don’t rush your application. If you’re approaching 6 months post-stent but haven’t had recent cardiac function testing, wait until you have updated echocardiogram and stress test results showing good function. If you’re at 11 months with a stable course, waiting until 12 months might qualify you for better rates at some carriers. Patience can pay off.
Realistic Impact: Optimal cardiac management might improve your rate class from Table F to Table E, or Table E to Table D. This represents a 25% premium reduction—substantial savings over a 20-30 year policy. However, optimal management won’t guarantee improvement from a Table F to standard rates. Set realistic expectations while doing everything possible to achieve the best outcome within the constraints of your cardiac history.
Required Documentation and Records
Stent recipient applications require extensive cardiac documentation. Underwriters need complete information to assess your risk accurately. Missing records delay decisions and sometimes worsen outcomes if underwriters make conservative assumptions in the absence of documentation.
Cardiac Catheterization Report
Your catheterization report is the most critical document. This detailed report describes which coronary arteries had blockages, the degree of stenosis, how many stents were placed and where, whether the procedure was elective or emergent, and whether you had evidence of acute myocardial infarction. Underwriters will request this report from your cardiologist. Having a copy ready expedites the process.
Echocardiogram Results
A recent echocardiogram documenting your ejection fraction and overall cardiac function is required. Underwriters prefer echocardiograms within the past 6-12 months. If your most recent echo is older than 12 months, consider getting an updated study before applying. This shows the current function rather than outdated information.
Stress Test Results
Recent stress test results showing your functional capacity and whether you have inducible ischemia (evidence of inadequate blood flow during exercise) are important. Good stress test results—completing appropriate workload without symptoms or EKG changes—support better underwriting outcomes. Poor stress test results, indicating significant residual ischemia, require more conservative underwriting.
Cardiology Records and Follow-Up Notes
Underwriters will request all cardiology records since your stent placement. These notes document your symptoms, functional status, medication adjustments, and your cardiologist’s assessment of your stability. Regular follow-up with documented stability supports approval. Gaps in care or concerning symptoms documented in these notes worsen outcomes.
Current Medication List
Complete the current medication list with doses. This helps underwriters assess disease severity and treatment complexity. Extensive cardiac medication regimens suggest substantial disease burden, while simpler regimens indicate less severe disease.
Pro Tip: Request copies of all these records from your cardiologist before applying. Having complete documentation ready to provide can reduce underwriting time from 8-10 weeks to 6-8 weeks. Your cardiologist’s office may charge a records fee, but this investment expedites your application and ensures underwriters have complete information for optimal decisions.
Complete Disclosure Requirements
Life insurance applications require complete disclosure of all medical conditions, procedures, and treatments. With a cardiac stent history, disclosure is particularly critical because underwriters will obtain extensive medical records that document everything.
You must disclose the exact date of stent placement, the reason for stenting (acute MI versus elective procedure), how many stents were placed, which coronary arteries were involved, and all follow-up procedures or complications. If you’ve had multiple cardiac procedures over time, list all of them with dates.
Disclose all cardiac diagnoses, including coronary artery disease, prior myocardial infarction if applicable, heart failure if present, and any cardiac arrhythmias. List all cardiac medications you take. Don’t minimize your cardiac history—underwriters will obtain complete records, and any omissions create serious problems, including potential claim denial.
If you’ve experienced chest pain, shortness of breath, or other cardiac symptoms since stent placement, disclose these symptoms. If you’ve had emergency room visits or hospitalizations for cardiac issues, report these with dates and outcomes. Complete honesty protects your coverage and your family.
Critical Warning: Do not minimize or downplay your cardiac stent history. Some applicants try to describe their stent as “minor” or suggest it’s “completely resolved.” A cardiac stent is never minor, and coronary artery disease is never resolved—it’s managed. Misrepresenting your cardiac history as less serious than it is constitutes a material misrepresentation that can void your coverage. Be completely honest about your cardiac disease.
Underwriting Timeline
Underwriting for cardiac stent recipients takes significantly longer than standard applications. The complexity of cardiac records review and the need for multiple specialist reports extend the timeline.
Expect 6-10 weeks from application submission to final decision. Some cases take 12+ weeks if records are incomplete or if underwriters request additional testing or specialist reports. This extended timeline reflects a thorough evaluation—underwriters are carefully assessing complex cardiac disease to assign appropriate risk classification.
The process typically follows this sequence: application submission, medical exam with EKG, requests for an attending physician’s statement to your cardiologist, review of cardiology records, possible requests for additional documentation or updated testing, underwriter review of all information, rate class assignment, and final decision. Each step takes time, particularly obtaining cardiology records, which may take 2-4 weeks.
Some carriers offer accelerated underwriting for certain applicants, but recipients of cardiac stents typically don’t qualify for these expedited processes. Your application requires traditional full underwriting, accompanied by a comprehensive medical review. Be patient with the timeline—thorough evaluation ultimately benefits you by ensuring you receive a fair, accurate risk assessment.
Timeline Management: If you need coverage by a specific date—perhaps for estate planning or business purposes—start the application process at least 3-4 months before your deadline. This allows time for the waiting period (if you’re close to the minimum), record gathering, underwriting review, and potential delays. Don’t wait until you urgently need coverage to begin the process.
Common Questions: Answered
Can I get life insurance after receiving a cardiac stent?
Direct answer: Yes, after a waiting period of 6-12 months, but expect significant rate increases.
Life insurance is available for stent recipients after appropriate waiting periods. Nearly all carriers require 6-12 months post-stent before considering applications. After this period, approval is likely but with rated policies—typically 175-300% above standard rates, depending on your specific cardiac status, ejection fraction, and disease extent.
Can I ever get standard rates after having a stent?
Direct answer: No. Standard rates are not available with a history of coronary artery disease.
Cardiac stent placement confirms significant coronary artery disease—a permanent change in your health classification. Standard rates are reserved for applicants without major chronic conditions. All stent recipients face rated policies reflecting cardiovascular mortality risk. Best-case outcomes achieve Table D (175% of standard). More typical outcomes range from Table E to H (200-300% of standard).
How long do I have to wait after stent placement before applying?
Direct answer: Most carriers require 6-12 months. Applying earlier results in automatic postponement.
Typical waiting periods are 6 months minimum, with many carriers preferring 12 months, especially for acute MI cases. Some conservative carriers require 18-24 months. If you apply before the waiting period expires, you’ll be postponed and asked to reapply later. Use this waiting period to optimize your cardiac management and accumulate stable follow-up records.
Does it matter if I had one stent versus multiple stents?
Direct answer: Yes. Single-vessel disease is underwritten more favorably than multi-vessel disease.
One stent indicating single-vessel disease suggests less extensive coronary atherosclerosis than multiple stents indicating multi-vessel disease. A single stent might qualify for Table D or E (175-200% of standard). Multiple stents typically result in Table F to H (225-300% of standard). Left main disease or complex three-vessel disease results in maximum table ratings or possible decline.
What if my stent was placed during a heart attack?
Direct answer: Expect higher rates than elective stenting, typically one to two table ratings worse.
Emergency stenting during acute myocardial infarction indicates you’ve had myocardial damage with potential for reduced cardiac function. This is underwritten more conservatively than elective stenting for stable angina. Your ejection fraction becomes particularly important. Normal function despite MI might still achieve Table E or F. Reduced ejection fraction after MI results in Table G to H or higher.
Is ejection fraction really that important?
Direct answer: Absolutely. Ejection fraction is one of the most critical underwriting factors.
Normal ejection fraction (above 50-55%) with stent history might achieve Table D to F, depending on other factors. Mildly reduced function (45-50%) results in Table E to G. Moderately reduced function (35-45%) results in Table G to H+. Severely reduced function (below 35%) often results in decline or maximum table ratings exceeding 300% of standard. Ejection fraction directly correlates with heart failure risk and mortality.
Can I still get coverage if I continue smoking after my stent?
Direct answer: Possibly, but many carriers decline smoking stent recipients or offer maximum table ratings.
Continued smoking after stent placement dramatically increases your risk of stent thrombosis, disease progression, and future cardiac events. Some carriers automatically decline smoking stent recipients. Others offer coverage at Table H+ (300%+ of standard). Stopping smoking completely for at least 12 months significantly improves your underwriting outcome and is critical for your cardiac health.
What if I’ve had additional cardiac procedures since my stent?
Direct answer: Each new procedure resets the waiting period and worsens your rate class.
Additional stents, repeat catheterizations, bypass surgery, or other cardiac interventions indicate progressive coronary disease. Each new procedure requires a new waiting period starting from the most recent intervention. Progressive disease requiring multiple procedures results in substantially higher rates—often Table H or above—or possible decline if disease progression is rapid or extensive.
Should I shop multiple carriers?
Direct answer: Yes. Different carriers have different underwriting guidelines and may offer different rate classes.
One carrier might offer Table E while another offers Table F for an identical cardiac history—a 25% premium difference. Working with an independent broker who can shop multiple carriers increases your chance of finding the best available rates. However, all carriers will rate your application significantly above standard. Shopping helps find the least expensive rated policy, not standard rates.
What if I’m declined?
Direct answer: Consider guaranteed issue policies or wait longer for cardiac stability before reapplying.
If your cardiac disease is too severe for standard underwritten coverage—extensive multi-vessel disease, severely reduced ejection fraction, progressive disease—you might be declined. Options include guaranteed issue whole life policies (limited coverage, high premiums, but no medical questions), waiting for improved stability and trying again in 6-12 months, or group coverage through employment if available. A decline isn’t permanent—cardiac improvement might enable approval later.
Life Insurance After Heart Stent Is Possible
Receiving a cardiac stent doesn’t make life insurance impossible, but it does require patience, realistic expectations, and acceptance of higher premiums. After appropriate waiting periods, most stent recipients can obtain rated coverage. Your family’s financial protection is achievable despite your cardiac history.
Call Now: 888-211-6171
Licensed agents understand cardiac underwriting and provide honest assessments of your coverage options. We’ll explain realistic rate expectations and help you find the best available coverage for your specific cardiac situation.
Disclaimer: This information is for educational purposes and does not constitute legal, medical, or insurance advice. Life insurance availability and pricing for applicants with cardiac stent history vary by individual circumstances, insurance company, and state regulations. Cardiac stent placement indicates significant coronary artery disease requiring comprehensive medical evaluation. Specific underwriting decisions depend on evaluation of stent placement circumstances, number and location of stents, current cardiac function, ejection fraction, symptom control, disease progression, cardiovascular risk factors, and insurance company guidelines. Coronary artery disease is a major underwriting factor. If you have concerns about your cardiac health, consult with your healthcare provider or cardiologist. Complications including heart failure, recurrent myocardial infarction, progressive coronary disease, or reduced cardiac function substantially affect life insurance rates or eligibility.
